The U.S. Food and Drug Administration has extended its review for the expanded use of Travere Therapeutics’ drug to treat a type of rare kidney disorder, the drugmaker said on Tuesday.
Medically reviewed by David Hampton, MD C3G is caused by immune system dysfunction that can lead to kidney issues.When the kidneys don't work as they should, people can experience blood or protein in ...
The Brighterside of News on MSN
Single gene reveals why inflammation triggers kidney failure
Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...
In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...
One 26-year-old mother of six in Arkansas is reaching out for the public’s help as she battles stage 5 kidney failure and ...
Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...
The incidence of kidney disease is substantially higher in patients with Down syndrome than in control individuals from the ...
ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat ...
HPT, HP, and HK in the 7MM and a moderate sales growth forecast highlight market opportunities. Significant unmet needs and emerging pipeline products present avenues for market expansion and ...
Chronic kidney disease (CKD) severity is associated with an increased risk for gastroparesis, according to a study published ...
Hypertension, diabetes, and cardiovascular disease are among the common causes of kidney failure. In the United States, approximately 35.5 million people have chronic kidney disease (CKD). 1 For some, ...
Officer Quas’Jon “Q” Flowers, 25, and a two-year veteran of the Albany Police Department, was diagnosed with advanced kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback